Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women
30 settembre 2021 aggiornato da: Andri Steinþór Björnsson, University of Iceland
Using a Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women
This research study is an extension on a study already preregistered NCT04209283 and is designed to investigate the use of a simple cognitive task (a memory cue followed by playing the computer game "Tetris") for decreasing the number of intrusive memories of trauma among trauma-exposed women in Iceland.
This is a single case series using a within subject multiple baseline AB design.
Participants will aim to complete a no-intervention phase ('A': baseline phase) of one week followed by a one-week intervention phase ('B'), including a one-session intervention with a researcher comprising the simple cognitive task, followed by instructions to continue using the technique self-guided in subsequent weeks.
Participants will be asked to monitor the occurrence of intrusive memories of trauma in a daily diary.
It is predicted that participants will report fewer intrusive memories during the intervention phase than during the preceding baseline phase and that the frequency of targeted intrusive memories is going to decrease relative to non-targeted intrusive memories.
Furthermore, the investigators will explore whether having fewer intrusive memories has an impact on function and/or PTSD, depressive or anxiety symptoms.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Participants will attend 3-8 sessions with researchers and sessions will be conducted remotely via telephone or secure video platform (Kara Connect).
In session one, the intrusive memories will be logged for monitoring their frequency in a daily diary for the following weeks.
Baseline assessment questionnaires will also administered.
In the second session, a memory will be selected and targeted with the intervention (memory reminder followed by 25 min gameplay with mental rotation) followed by monitoring the frequency of both the targeted and non-targeted intrusive memories.
Participants will also complete self-rated questions concerning the impact of their intrusive memories.
The intervention session will be repeated for other intrusive memories (maximum 6 intervention sessions).
In the last intervention session, participants will be asked to complete questionnaires and self-rated questions assessing the impact of their intrusive memories.
Participants will be asked to complete measures at 1 month follow-up and at 3 month follow-up.
In the 1 month follow-up and the 3 month follow-up, participants complete questionnaires and monitor the frequency of intrusive memories for one week.
The investigators note that the intended timeframes (e.g.
one-week for baseline and one-week for intervention phase) may differ slightly across participants depending on availability and the practicalities of remote delivery.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
10
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Reykjavík, Islanda, 101
- University of Iceland
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 14 anni a 65 anni (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Femmina
Descrizione
Inclusion Criteria:
- Having experienced at least one criterion A trauma according to the DSM-5
- Having at least one intrusive memory that occurs at least three times per week in the past four weeks
- Being able to attend 3-8 sessions with researcher
- Being willing to monitor intrusive memories in daily life
- Having access to a smartphone
- Being able to speak Icelandic and read study materials in Icelandic
Exclusion Criteria:
- Current psychotic disorder (determined by the psychotic module on the Mini International Neuropsychiatric Interview (MINI)).
- Current manic episode (determined by the bipolar module on the Mini International Neuropsychiatric Interview (MINI)).
- Being acutely suicidal (according to the module assessing suicidality on the Mini International Neuropsychiatric Interview (MINI)).
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Trauma exposed women
No Intervention: Baseline phase ('A'): Measurements collected in a daily diary four times a day (morning, afternoon, evening and night) over one week for the primary outcome (occurrence of intrusive memories of trauma). Individual baseline phases will be used as control periods. Experimental: Intervention phase ('B'): A one-session intervention with a researcher including a simple cognitive task (a memory cue and 25 minutes of Tetris game-play with mental rotation) followed by instructions to engage in the task self-guided over the subsequent week. Measurements collected in a daily diary four times a day following the intervention for the primary outcome (occurrence of intrusive memories of trauma). Intervention: Behavioral: Brief cognitive intervention |
Behavioral: Brief cognitive intervention.
A one-session intervention with a researcher including a simple cognitive task (a memory cue and 25 minutes of Tetris game play with mental rotation) with instructions to engage in the task self-guided in the subsequent weeks.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in the number of intrusive memories of trauma
Lasso di tempo: Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up
|
Number of intrusive memories of traumatic event recorded by participants in a diary daily (morning, afternoon, evening and night) for one week during the baseline phase and each week during the intervention phase (week 1-6) and during one week at one month follow-up and three month follow-up.
|
Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Self-guided intervention adherence - usage of the gameplay intervention in daily life
Lasso di tempo: Intervention week 2-6
|
How often did you manage to play Tetris after you experienced an intrusive memory?
(11-point scale; 0 = not at all; 10 = every time).
|
Intervention week 2-6
|
|
Feasibility and acceptability ratings for using a smartphone game-play intervention
Lasso di tempo: Post intervention up to week 7
|
Feasibility and Acceptability of the intervention assessed with two self-rated items, "Would you recommend playing Tetris to a friend?" and "Do you consider gameplay to be an acceptable way to reduce the daily frequency of intrusive memories?".
Scores could range from 0 - 10 with higher scores indicating greater acceptability/feasibility.
|
Post intervention up to week 7
|
|
Feasibility and acceptability - open ended questions
Lasso di tempo: Post intervention up to week 7
|
Two open-ended questions: 1. "How did you feel about playing Tetris after you had an intrusive memory?" 2. "Did you find the intervention helpful?
If yes, how?"
|
Post intervention up to week 7
|
|
Impact of intrusive memories on concentration, sleep and stress - ratings
Lasso di tempo: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
Six self-rated items to assess the impact of intrusive memories on concentration, sleep, and stress in the past week.
2 items assessing concentration difficulties in general and due to intrusive memories (11-point scale; high scores indicating more difficulties).
2 items assessing sleep disturbances due to intrusive memories (11-point scale; higher scores indicating more sleep disturbance); and 1 item assessing to what degree intrusive memories affected stress levels (0 = not at all; 10 = affected very much).
|
Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
|
Rating of how long intrusive memories disrupted concentration on average
Lasso di tempo: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
1 item assessing for how long intrusive memories disrupted concentration on average on a 6-point scale (0 = <1 minute - 6 = > 60 minutes)
|
Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
|
General impact of intrusive memories - ratings
Lasso di tempo: Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up
|
Two items both rated on an 11-point scale: 1. "During the last week, how distressing were your intrusive memories (0 = not at all; 10 = very distressing).
2. During the last week, how vivid were your intrusive memories (0 = not at all; 10= very vivid)
|
Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up
|
|
Intrusion diary adherence
Lasso di tempo: Baseline phase week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up
|
Adherence to the intrusion diary assessed with 1 item: "How accurately did you fill out the diary?" (0= not at all; 10 = very accurately)
|
Baseline phase week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up
|
|
The Posttraumatic Stress Disorder Checklist 5 (PCL-5)
Lasso di tempo: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
The PCL-5 is a short 20-item self-report scale used to assess the severity of PTSD symptoms corresponding to the DSM-5 criteria for PTSD.
Symptoms are rated from 0-4.
Higher scores indicate greater severity.
|
Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
|
The Patient Health Questionnaire-9 (PHQ-9)
Lasso di tempo: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
The PHQ-9 is a 9-item self-report measure of depression symptoms and the severity of those symptoms.
Each item can be scored from 0 (i.e., not at all) to 3 (i.e., nearly every day).
|
Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
|
The Generalized Anxiety Disorder-7 scale (GAD-7)
Lasso di tempo: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
The GAD-7 is a brief self-report questionnaire designed as a screening tool for symptoms of general anxiety disorder and their severity.
Each item can be scored from 0 (i.e., not at all) to 3 (i.e., nearly every day).
|
Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
|
The Sheehan Disability Scale (SDS)
Lasso di tempo: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
The SDS is a self-report questionnaire which is designed to assess functional impairment across three domains: (1) Work/school, (2) social, and (3) family life.
These domains are measured on an 11-point scale which ranges from 0 (i.e., not at all) to 10 (i.e., extremely).
The scale will be adjusted to assess impairment associated with intrusive memories.
|
Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up
|
|
Impact of intrusive memories on functioning
Lasso di tempo: Baseline week 1; Post intervention up to week 7, 1 month follow-up and 3 month follow-up
|
Two questions assessing the impact intrusive memories have on functioning in daily life.
One question is open-ended: "Have the intrusive memories affected your ability to function in your daily life in the past week?
If yes, how?" and one question is self-rated: "Have the intrusive memories affected your ability to function in your daily life?" (11-point scale, higher score indicate greater impact on functioning.)
|
Baseline week 1; Post intervention up to week 7, 1 month follow-up and 3 month follow-up
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
8 settembre 2020
Completamento primario (Effettivo)
1 settembre 2021
Completamento dello studio (Effettivo)
1 settembre 2021
Date di iscrizione allo studio
Primo inviato
8 aprile 2020
Primo inviato che soddisfa i criteri di controllo qualità
10 aprile 2020
Primo Inserito (Effettivo)
13 aprile 2020
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
1 ottobre 2021
Ultimo aggiornamento inviato che soddisfa i criteri QC
30 settembre 2021
Ultimo verificato
1 settembre 2021
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- VIRMT
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
No
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .